Tech Energy Business Strategy Videos Awards
Tech Energy Business Strategy Videos Awards

A fairy godmother for research and development in biopharmaceuticals

Only five percent of candidate drugs currently make it through the initial R&D phase. With demand for novel biopharmaceuticals growing, Batavia Biosciences is helping organisations improve their development processes

Chinese regulator approves landmark homegrown cancer treatment drug

The cancer-treating drug was discovered and developed entirely on Chinese soil, a first for the country’s pharmaceutical sector

Takeda and Shire finally agree takeover terms after months of negotiations

Irish pharmaceutical company Shire has finally accepted a takeover offer from Japan’s Takeda, bringing an end to a saga that has seen four previous bids rejected by the Dublin-based drug maker

Novartis to acquire gene therapy specialist AveXis for $8.7bn

Swiss pharmaceutical company Novartis has sought to build on its leading position in the gene therapy market with the purchase of AveXis – its second major gene therapy deal this year

Shares fall as Sanofi announces $11.6bn deal to acquire Bioverativ

French healthcare group Sanofi witnessed a sharp fall in its share price after acquiring biotech company Bioverativ for a premium, but maintains the deal will add to its earnings per share in the current financial year

Chinese cancer drug one step closer to the international market

The China Food and Drink Administration will review a new drug developed by Chi-Med as possible cancer treatment

Thermo Fisher acquires Patheon for $7.2bn

Scientific instruments maker Thermo Fisher has acquired a Dutch drug company in new push towards biopharma manufacturing

Aquinnah offers new hope for ageing brains

The discovery of stress granules and their role in neurodegenerative disease has opened up new possibilities for the treatment of ALS and Alzheimer’s disease, according to Aquinnah Pharmaceuticals

Japan’s Takeda sets aside $15bn for US pharmaceutical acquisitions

Japan’s biggest pharmaceutical company sets its sights on foreign takeovers as it looks to bolster its position in the global drugs market

Gold-standard lupus treatment Lupuzor begins phase III trial

Drug developer ImmuPharma successfully raises £8.4m to fund final trial of breakthrough lupus treatment

Five times technology clashed with the law

Regulation has always struggled to keep pace with technology. Here are five of the biggest clashes between lawmen and innovators

Pharmaceutical giants launch consortium with top universities

Imperial, Cambridge and UCL partner up with industry leaders AstraZeneca, GlaxoSmithKline and Johnson & Johnson to advance new treatments